Clinical Trials Browser

Phase 1 × Recruiting × Radiosurgery × Clear all

NCT06211335 2026-03-12

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06369246 2026-03-09

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

Phase 1 Recruiting

Advanced Prostate Cancer

NCT06492954 2026-03-02

AflacST2301

Phase 1 Recruiting

Osteosarcoma

NCT05488522 2026-02-20

SBRT With Atezo/Bev for HCC

Phase 1 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05371132 2026-01-28

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Phase 1 Recruiting

Lymphoma, Neoplasm Metastasis

NCT06287515 2026-01-14

Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain

Phase 1 Recruiting

Hypophysectomy

NCT05030298 2025-11-21

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Phase 1 Recruiting

Glioma

NCT05079698 2025-11-10

A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT04518748 2025-08-05

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

Phase 1 Recruiting

Liver Malignancy

NCT04572451 2025-08-01

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Phase 1 Recruiting

Melanoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site

NCT06130826 2025-05-30

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT02390518 2025-05-07

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Phase 1 Recruiting

Brain Neoplasms

NCT05615142 2024-04-17

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Phase 1 Recruiting

NSCLC